SEC Form 4 · accession 0000891293-15-000016
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Louis A Bianco
Officer — EVP,Finance and Administration
Period of report
Apr 23, 2014
Accepted (ET)
Apr 24, 2015 · 5:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 23, 2015 | S | 10,000 | $1.93 | D | 945,416 | D | |
| Common Stock | holding | — | — | — | 37 | I | Trust for Children |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a rule 10b5-1 trading plan.